510(k) K761009

LYMPHOCYTE TYPING, POSITIVE CONTROL by Hyland Therapeutic Div., Travenol Laboratories — Product Code LGO

K761009 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "LYMPHOCYTE TYPING, POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on Apr 6, 1977. The device falls under product code LGO (Test, Leukocyte Typing), a Class I device regulated under 21 CFR 864.7675. Hyland Therapeutic Div., Travenol Laboratories has 43 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 6, 1977
Date Received
Nov 2, 1976
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Test, Leukocyte Typing
Device Class
Class I
Regulation Number
864.7675
Review Panel
HE
Submission Type
510(k) Exempt

Need the full FDA record for Hyland Therapeutic Div., Travenol Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K761009. Report a data issue: hello@regdatalab.com.